Compassionate use of an antisense drug first used at Columbia to treat an aggressive type of ALS caused by mutations in the FUS gene markedly reduces toxic proteins in the nervous system.
Just a single type of neuron controls the complex patterns of walking, a surprising finding that may lead to new therapeutic approaches for people with spinal cord injuries.
A new study at Columbia University Irving Medical Center seeks volunteers to determine if intermittent fasting leads to long-term weight loss and health benefits.
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
Dr. Maura Boldrini, a neuroscientist at Columbia University, says new research could have far-reaching implications for other mental illnesses beyond COVID.
